TTI:TSXV, Thiogenesis Therapeutics, Corp.

TTI stock overview

Thiogenesis Therapeutics, Corp. (TTI:TSXV) closed at $0.500 on October 14, 2026, down 9.09% on the day. The stock trades 38.3% below its 52-week high of $0.810 and 13.6% above its 52-week low of $0.440. Over the past year, it lost 23.6%. Thiogenesis Therapeutics, Corp. is part of the Health Care sector.

Key figures

Price: $0.500
Day change: -9.09%
Volume: 19,000
Average volume: 29,882
Market cap: 34M+
52-week range: $0.440 – $0.810
50-day average: $0.521
200-day average: $0.550

Performance

5D	1M	3M	6M	1Y
+3.77%	+10.00%	+3.77%	-9.84%	-23.61%

Price action over the past year

In 252 trading sessions since October 14, 2025, TTI closed higher on 64 days (25%). Its best day was April 14, 2026 (+18.52%) and its worst was March 11, 2026 (-15.25%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 15 times.

Recent signals

Oct 13, 2026: Hit a new 2-Week High of $0.550 (New Highs/Lows scanner)
Oct 13, 2026: Trading sideways between $0.490 and $0.560 over 30 days (Sideways scanner)
Sep 21, 2026: News catalyst: Investor Update (News Catalysts scanner)

TTI news

Sep 21, 2026: Thiogenesis Reports Results of 2026 Annual and Special Meeting of Shareholders and Provides Corporate Update

About Thiogenesis Therapeutics, Corp.

Thiogenesis Therapeutics Corp is an early stage biotech company. It is developing novel drug formulations that act as precursors to cysteamine, which is a small aminothiol compound that is endogenous in humans in small quantities.

Find more stocks like TTI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.